February 21, 2018 / 12:10 PM / 8 months ago

BRIEF-NeoGenomics Reports Q4 Adjusted EPS Of $0.05

Feb 21 (Reuters) - NeoGenomics Inc:

* NEOGENOMICS REPORTS REVENUE OF $67.8 MILLION ON 18.7% CLINICAL VOLUME GROWTH AND $10.5 MILLION OF ADJUSTED EBITDA IN THE FOURTH QUARTER OF 2017

* SEES FY 2018 REVENUE $260 MILLION TO $272 MILLION

* SEES 2018 ‍GAAP DILUTED EPS TO BE A LOSS OF $0.13 TO $0.08 PER SHARE​

* SEES 2018 ‍ADJUSTED DILUTED EPS TO BE $0.15 - $0.20 PER SHARE​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below